ceric oxide has been researched along with malondialdehyde in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, W; Chen, E; Chen, H; Cheng, G; Guo, W; Han, L; Kong, L; Li, H; Song, N; Wang, L | 1 |
| Abdollahi, M; Baeeri, M; Bayrami, Z; Cheshmehnour, J; Hassani, S; Hosseini, A; Najafi, R; Rayegan, S; Safa, M; Sharifi, AM | 1 |
| Darroudi, M; Ghayour-Mobarhan, M; Hashemzadeh, A; Khorrami, MB; Pasdar, A; Riahi-Zanjani, B; Sadeghnia, HR; Zare, M | 1 |
| Carvajal, S; Casals, E; Casals, G; Fernández-Varo, G; González de la Presa, B; Jiménez, W; Morales-Ruíz, M; Oró, D; Parra, M; Pastor, Ó; Perramón, M; Puntes, V; Ribera, J | 1 |
| Nahavandi, A; Shahbazi, A; Zavvari, F | 1 |
| Beyranvand, F; Gharzi, A; Gholami, M; Mousavi, A; Takesh, M | 1 |
| Dong, Y; Wen, Y; Yang, Y; Zhao, M; Zhao, Y | 1 |
| Abd El-Monem, AM; Ali, RH; El Agaty, SM; Galal Hamam, G; Lasheen, NN; Lebda, FM | 1 |
1 trial(s) available for ceric oxide and malondialdehyde
| Article | Year |
|---|---|
Effect of Cerium Oxide Nanoparticles on Myocardial Cell Apoptosis Induced by Myocardial Ischemia-Reperfusion Injury.
Topics: Animals; Antioxidants; Apoptosis; Cerium; Male; Malondialdehyde; Myocardial Reperfusion Injury; Nanoparticles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase | 2022 |
7 other study(ies) available for ceric oxide and malondialdehyde
| Article | Year |
|---|---|
Cerium oxide nanoparticles induce cytotoxicity in human hepatoma SMMC-7721 cells via oxidative stress and the activation of MAPK signaling pathways.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Catalase; Cell Line, Tumor; Cell Survival; Cerium; Glutathione Peroxidase; Humans; Malondialdehyde; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nanoparticles; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase | 2013 |
Cerium and yttrium oxide nanoparticles against lead-induced oxidative stress and apoptosis in rat hippocampus.
Topics: Animals; Antioxidants; Apoptosis; Catalase; Cerium; Hippocampus; Lipid Peroxidation; Male; Malondialdehyde; Nanoparticles; Oxidative Stress; Rats; Superoxide Dismutase; Yttrium | 2015 |
Antioxidant and toxicity studies of biosynthesized cerium oxide nanoparticles in rats.
Topics: Animals; Antioxidants; Biomarkers; Catalase; Cerium; Iron; Kidney; Liver; Male; Malondialdehyde; Nanoparticles; Oxidation-Reduction; Oxidative Stress; Rats, Wistar; Sulfhydryl Compounds; Superoxide Dismutase; Toxicity Tests | 2019 |
Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.
Topics: Adipokines; Animals; Body Weight; Cerium; Cholesterol; Choline; Diet; Fatty Acids; Gene Expression Regulation; Inflammation; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine; Nanoparticles; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Wistar; Signal Transduction; Triglycerides | 2019 |
Neuroprotective effects of cerium oxide nanoparticles on experimental stress-induced depression in male rats.
Topics: Animals; Cell Proliferation; Cell Survival; Cerium; Depression; Hippocampus; Interleukin-6; Male; Malondialdehyde; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Rats; Stress, Psychological | 2020 |
The therapeutic effect of cerium oxide nanoparticle on ischaemia/reperfusion injury in rat testis.
Topics: Animals; Cerium; Humans; Ischemia; Male; Malondialdehyde; Nanoparticles; Rats; Reperfusion Injury; Spermatic Cord Torsion; Testis | 2021 |
Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cerium; Dyslipidemias; Fatty Acids, Nonesterified; Female; Fibrosis; Fructose; Humans; Liver; Liver X Receptors; Malondialdehyde; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Ovariectomy; Postmenopause; Rats; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |